Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Beta Endorphin
2. Beta-endorphin
3. Beta-endorphin (1-31)
4. Endorphin, Beta
1. 61214-51-5
2. Beta-endorphin
3. Unii-3s51p4w3xq
4. Einecs 262-330-3
5. 3s51p4w3xq
6. Gtpl1643
7. Schembl6238339
8. Chembl1866903
9. 27-l-tyrosine-31-l-glutamic Acid-beta-endorphin (sheep)
10. Beta-endorphin (human Synthetic)
11. Dtxsid30210135
12. Mfcd00076383
13. Beta-endorphin Human Synthetic
14. Beta-endorphin Human, >=95% (hplc)
15. Ncgc00163196-01
16. Ncgc00163196-02
17. As-83086
Molecular Weight | 3465.0 g/mol |
---|---|
Molecular Formula | C158H251N39O46S |
XLogP3 | -13.9 |
Hydrogen Bond Donor Count | 48 |
Hydrogen Bond Acceptor Count | 53 |
Rotatable Bond Count | 118 |
Exact Mass | 3463.8254677 g/mol |
Monoisotopic Mass | 3462.8221128 g/mol |
Topological Polar Surface Area | 1430 Ų |
Heavy Atom Count | 244 |
Formal Charge | 0 |
Complexity | 7850 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 33 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Neurotransmitter Agents
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?